These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular advances of brain tumors in radiation oncology. Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A. Semin Radiat Oncol; 2009 Jul 01; 19(3):171-8. PubMed ID: 19464632 [Abstract] [Full Text] [Related]
4. Current and emerging molecular targets in glioma. Roesler R, Brunetto AT, Abujamra AL, de Farias CB, Brunetto AL, Schwartsmann G. Expert Rev Anticancer Ther; 2010 Nov 01; 10(11):1735-51. PubMed ID: 21080801 [Abstract] [Full Text] [Related]
5. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Hargrave D. Br J Neurosurg; 2009 Aug 01; 23(4):351-63. PubMed ID: 19637006 [Abstract] [Full Text] [Related]
6. Molecularly targeted therapies for malignant gliomas: advances and challenges. Penas-Prado M, Gilbert MR. Expert Rev Anticancer Ther; 2007 May 01; 7(5):641-61. PubMed ID: 17492929 [Abstract] [Full Text] [Related]
7. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies. Argyriou AA, Antonacopoulou A, Iconomou G, Kalofonos HP. Crit Rev Oncol Hematol; 2009 Mar 01; 69(3):199-210. PubMed ID: 18602834 [Abstract] [Full Text] [Related]
8. Malignant glioma drug discovery - targeting protein kinases. Sathornsumetee S, Vredenburgh KA, Lattimore KP, Rich JN. Expert Opin Drug Discov; 2007 Jan 01; 2(1):1-17. PubMed ID: 23496034 [Abstract] [Full Text] [Related]
10. Therapeutic targeting of EGFR in malignant gliomas. Ye F, Gao Q, Cai MJ. Expert Opin Ther Targets; 2010 Mar 01; 14(3):303-16. PubMed ID: 20148717 [Abstract] [Full Text] [Related]
13. Novel therapies for malignant gliomas: a local affair? Rainov NG, Söling A, Heidecke V. Neurosurg Focus; 2006 Apr 15; 20(4):E9. PubMed ID: 16709040 [Abstract] [Full Text] [Related]
14. Editorial review: targets for glioma treatment: from bench to bedside. Sanson M. Curr Opin Oncol; 2008 Nov 15; 20(6):650-1. PubMed ID: 18841046 [Abstract] [Full Text] [Related]
15. Novel therapies for malignant gliomas. Cavaliere R, Wen PY, Schiff D. Neurol Clin; 2007 Nov 15; 25(4):1141-71, x. PubMed ID: 17964029 [Abstract] [Full Text] [Related]
16. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors. Idbaih A, Ducray F, Sierra Del Rio M, Hoang-Xuan K, Delattre JY. Oncologist; 2008 Sep 15; 13(9):978-92. PubMed ID: 18779539 [Abstract] [Full Text] [Related]
17. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Newton HB. Curr Opin Investig Drugs; 2007 Dec 15; 8(12):1009-21. PubMed ID: 18058572 [Abstract] [Full Text] [Related]
18. Targeted therapy for malignant gliomas. Morokoff AP, Novak U. J Clin Neurosci; 2004 Nov 15; 11(8):807-18. PubMed ID: 15519855 [Abstract] [Full Text] [Related]
19. Glioma stem cell signaling: therapeutic opportunities and challenges. Dietrich J, Diamond EL, Kesari S. Expert Rev Anticancer Ther; 2010 May 15; 10(5):709-22. PubMed ID: 20470003 [Abstract] [Full Text] [Related]